4742 (2024). Hon Dr Ayesha Verrall to the Associate Minister of Health

Written Question

Published date: 26 Apr 2024

Metadata

Document type:	Written Question
Parliament number:	54
Question number:	4742 (2024)
Question asked:	02 Apr 2024
Member asking:	Hon Dr Ayesha Verrall
Portfolio:	Associate Minister of Health
Minister replying:	Hon David Seymour
Answer received:	20 Apr 2024
Status:	Question Answered
Reply type:	Reply
Document ID:	WQ_04742_2024
Document guid:	d4fa593f-6d93-452f-972c-838dc609eee3

4742 (2024). Hon Dr Ayesha Verrall to the Associate Minister of Health: What progress, if any, has been made in the last quarter (September to December 2023), toward implementing the recommendation to ‘have stronger oversight by the board of the pharmaceutical investment decision making, with a focus on what is not funded alongside what is funded. This should include ongoing quality assurance oversight of the investment decision-making process’ from the Pharmac Review final report?

Hon David Seymour: I refer the Member to reply number 4741 (2024)